What happened
Korea United Pharm filed provisional (unaudited) separate results for Q1 2026: revenue of US$50.1M (+3.5% year on year), operating profit of US$7.64M (−18.3% year on year) and net income of US$9.49M (+10.5% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$50.1M |
|---|---|
| Revenue vs a year earlier | +3.5% |
| Operating profit | US$7.64M |
| Net income | US$9.49M |
| Period | Q1 2026 (separate) |
| Filed | 2026-04-30, Operating results (preliminary) (fair disclosure) |
| Source | DART rcept 20260430801578 → open original filing |
Source: DART. Information only, not investment advice.